EYPT - EyePoint Pharmaceuticals Director sells stock worth $37M
2024-01-17 06:00:39 ET
More on EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal
- Countdown To Clarity: EyePoint's December Data Delivery
- EyePoint commences $175M stock offering to advance wet AMD therapy into late-stage
For further details see:
EyePoint Pharmaceuticals Director sells stock worth $37M